Value of combining biological age with assessment of individual frailty to optimize management of cancer treated with targeted therapies: Model of chronic myeloid leukemia treated with tyrosine kinase inhibitors (BIO-TIMER trial)

Định dạng: pdf / Số trang: 8

Nhắn tin với admin nếu không tải được